Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO


NEW YORK, Aug. 13, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Mesoblast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 11, 2020, the U.S. Food and Drug Administration ("FDA") released briefing materials for the August 13, 2020 meeting of the FDA's Oncologic Drugs Advisory Committee, at which the FDA will review and discuss Mesoblast's marketing application for Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.  The FDA briefing documents stated that it is "unclear" whether the study results supporting Mesoblast's application are "relevant" to the proposed indication for use. 

On this news, Mesoblast's stock price fell $6.09 per share, or 34.96%, to close at $11.33 per share on August 11, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected] 
888-476-6529 ext. 7980

 

SOURCE Pomerantz LLP


These press releases may also interest you

at 09:05
Hudson Pacific Properties, Inc. , a unique provider of end-to-end real estate solutions for tech and media tenants, today announced it will release first quarter financial results after the market closes on Wednesday, May 1, 2024. The company will...

at 09:00
KinderCare Learning Companies, a leading provider of early childhood and school-age education and care, proudly celebrates their eighth consecutive Gallup Exceptional Workplace Award (GEWA). KinderCare is one of just two companies worldwide that have...

at 09:00
Today, NEXT Insurance, a leading technology-first small business insurer, announced the availability of Copilot, a tool designed to help agents increase revenue by efficiently serving small micro businesses with customized insurance policies. Similar...

at 09:00
The European Bank for Reconstruction and Development (EBRD) is providing a senior loan of ? 30 million to Rönesans Gayrimenkul Yat?r?m A.? (Rönesans Real Estate Investment) subsidiary of Rönesans Holding, one of Europe's leading contracting and...

at 09:00
TMX Group Limited will announce its financial results for the first quarter ended March 31, 2024 in the evening of Thursday, May 2, 2024. An analyst conference call to review the results will be held at 8:00 a.m. EDT on Friday, May 3, 2024. TMX...

at 09:00
Aeovian Pharmaceuticals, a...



News published on and distributed by: